ABOUT THE PRODUCT
A BAFF-R targeting CAR-T cell therapy for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL) and mantle cell lymphoma (MCL).
Information is owner-confirmed
Last updated 1 month ago
Price range
Other products/services from Pepromene Bio
BAFF-R/CD3 Bispecific mAb
Biotechnology
N/A
Pepromene Bio
United States (US)